![](/img/cover-not-exists.png)
PND52 PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS SUBCUTANEOUS INTERFERON BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY
Gitlin, M., Snyder, S., Jhaveri, M.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.1822
Date:
November, 2019
File:
PDF, 321 KB
2019